Medical

GLP-1 Agonists Showed Dose-Specific ON-Medication Motor Effects in Parkinson’s Disease

by
GLP-1 Agonists Showed Dose-Specific ON-Medication Motor Effects in Parkinson's Disease

TL;DR: A 2026 systematic review and exploratory network meta-analysis of 5 randomized trials in Neurological Sciences found dose-specific ON-medication motor improvements, measured while usual Parkinson’s drugs were active, for some GLP-1 receptor agonists, glucose-related metabolic hormone drugs, in Parkinson’s disease, but broader motor, non-motor, and quality-of-life evidence remained limited. Key Findings 5 randomized trials: The …

Read more

Antipsychotic D2 Blockade May Disturb Pancreatic Insulin Secretion

by
Antipsychotic D2 Blockade May Disturb Pancreatic Insulin Secretion

TL;DR: A 2026 systematic review and meta-analysis in Neuropsychopharmacology found that dopamine D2-like receptor activation suppressed glucose-stimulated insulin secretion (GSIS), insulin release after high glucose, in animal pancreatic cells, suggesting one peripheral route by which antipsychotic dopamine blockade can disturb glucose control beyond weight gain. Key Findings 39 eligible studies: Researchers screened 12,457 citations and …

Read more

Half of 292 Adult ADHD Randomized Trials Skipped a General Psychopathology Assessment, Scoping Review Found

by
Half of 292 Adult ADHD Randomized Trials Skipped a General Psychopathology Assessment, Scoping Review Found

TL;DR: A 2025 scoping review in European Psychiatry screened 292 randomized trials of adults diagnosed with attention-deficit/hyperactivity disorder (ADHD) and reported that 49.7% did not assess general psychopathology and only 35% had the ADHD diagnosis allocated by a psychiatrist or psychologist. Key Findings Half of the trials skipped a general psychopathology check: 49.7% of the …

Read more

25C-NBF, a Selective 5-HT2A Phenethylamine, Reduced Despair and Restored Sucrose Preference in Male Mice

by
25C-NBF, a Selective 5-HT2A Phenethylamine, Reduced Despair and Restored Sucrose Preference in Male Mice

TL;DR: A 2026 mouse and rat study in Molecular Psychiatry reported that 25C-NBF, a selective serotonin 2A receptor agonist from the 2C-X phenethylamine series, produced rapid antidepressant-like effects, increased dendritic spines and Bdnf expression in the prefrontal cortex, and showed no rewarding or reinforcing properties at the tested doses. Key Findings Despair behavior fell after …

Read more

CBT-I Plus Medication Improved Chronic Insomnia More Than Medication Alone

by
CBT-I Plus Medication Improved Chronic Insomnia More Than Medication Alone

TL;DR: A 2026 systematic review in Journal of Clinical Sleep Medicine found that cognitive behavioral therapy for insomnia (CBT-I), a structured behavioral sleep treatment, plus sleep medication improved chronic insomnia more than medication alone, but adding medication to CBT-I did not improve the critical insomnia outcomes. Key Findings 15 analyzable articles: Researchers screened 1,179 articles, …

Read more

BIOMEDE Trial Found No Survival Gain From Targeted Drugs in DIPG

by
BIOMEDE Trial Found No Survival Gain From Targeted Drugs in DIPG

TL;DR: A 2026 randomized phase 2 trial in Nature Medicine found that three targeted drugs added to radiotherapy did not improve overall survival for children with diffuse intrinsic pontine glioma (DIPG), a lethal brainstem tumor, although everolimus caused fewer treatment-stopping side effects. Key Findings 233 randomized patients: BIOMEDE assigned 36 children to erlotinib, 102 to …

Read more

Olfactory MRI Radiomics Linked pTau217 to Alzheimer’s Cognition

by
Olfactory MRI Radiomics Linked pTau217 to Alzheimer's Cognition

TL;DR: A 2026 article-in-press study in Alzheimer’s Research & Therapy found that olfactory-region MRI radiomics, a method that turns brain scans into quantitative texture and shape features, linked blood pTau217, a tau-related Alzheimer’s disease biomarker, with cognitive impairment across three cohorts. Key Findings Three Alzheimer’s cohorts were matched: Researchers matched 122 Alzheimer’s disease (AD) patients …

Read more

Alzheimer’s AI Model Improved Disease Progression Prediction

by
Alzheimer's AI Model Improved Disease Progression Prediction

TL;DR: A 2026 machine-learning study found that the final SNP-NF model in PLOS One reported mAUC 0.965, recall 0.929, and precision 0.929, while the study reported gains of about 3% in mAUC, 1% in precision, and 0.7% in recall versus their previous neural-process model. Key Findings SNP-NF performance was high: The final model reported mAUC …

Read more

Natural Daylight During Office Hours Improved Glucose Time-in-Range and Shifted Substrate Metabolism in Type 2 Diabetes

by
Natural Daylight During Office Hours Improved Glucose Time-in-Range and Shifted Substrate Metabolism in Type 2 Diabetes

TL;DR: A 2026 randomized crossover trial in Cell Metabolism compared natural daylight against standard artificial office lighting in 13 older adults with well-controlled type 2 diabetes and found that natural-daylight days produced more time in a healthy blood-glucose range (about 51% vs 43%), smaller glucose swings, and a metabolic shift toward burning more fat and …

Read more

Three or More Live Births Was the Only Reproductive Factor Linked to Lower Stroke Risk in Framingham Women

by
Three or More Live Births Was the Only Reproductive Factor Linked to Lower Stroke Risk in Framingham Women

TL;DR: A 2026 study in the Journal of the American Heart Association followed 1,882 stroke-free women from the Framingham Heart Study for a median of 18 years and found that having three or more live births was associated with a reduced risk of clinical stroke and lower MRI markers of vascular brain injury — the …

Read more

+ Load more